EC Number | Application | Comment | Organism |
---|---|---|---|
2.7.1.150 | drug development | potential for targeting this kinase in developing small-molecule antivirals against SARS-CoV-2. The infection is fully blocked by bafilomycin A1, which inhibits the vacuolar type H+-ATPase (V-ATPase) acidification activity. Apilimod and vacuolin-1 prevent cytoplasmic entry of VSV-MeGFP-ZEBOV (from Zaire ebolavirus VSV-ZEBOV) | Homo sapiens |
2.7.1.150 | drug development | the enzyme is a potential target for developing small-molecule antivirals against SARS-CoV-2 | Homo sapiens |
EC Number | Inhibitors | Comment | Organism | Structure |
---|---|---|---|---|
2.7.1.150 | apilimod | an inhibitor of the main endosomal phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase, PIKfyve, and potent inhibitor of SARS-CoV-2 strain 2019-nCoV/USA-WA1/2020. The compound prevents cytoplasmic entry of MeGFP-tagged vesicular stomatitis virus (VSV)-ebolavirus (EBOV) construct VSV-MeGFP-ZEBOV, inhibition of VSV mutant entry, overview. The virus particles are able to enter functional endosomes in presence of apilimod; HY-14644, apilimod inhibits enzyme PIKfyve and infection of SARS-CoV-2 virus. The IC50 of apilimod in experiments with authentic virus is remarkably similar to (or even more potent than) that obtained with chimeric VSV-SARS-CoV-2 | Homo sapiens | |
2.7.1.150 | vacuolin-1 | an inhibitor of the main endosomal phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase, PIKfyve. The compound prevents cytoplasmic entry of MeGFP-tagged vesicular stomatitis virus (VSV)-ebolavirus (EBOV) construct VSV-MeGFP-ZEBOV, inhibition of VSV mutant entry, overview; vacuolin-1 inhibits enzyme PIKfyve | Homo sapiens |
EC Number | Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|---|
2.7.1.150 | endosome membrane | - |
Homo sapiens | 10008 | - |
2.7.1.150 | endosome membrane | cytosolic face of endosomal membranes as part of a ternary complex with the PI(3,5)P2 5-phosphatase Sac3 and ArPIKfyve | Homo sapiens | 10008 | - |
2.7.1.150 | vacuolar membrane | - |
Homo sapiens | 5774 | - |
EC Number | Metals/Ions | Comment | Organism | Structure |
---|---|---|---|---|
2.7.1.150 | Mg2+ | required | Homo sapiens |
EC Number | Natural Substrates | Organism | Comment (Nat. Sub.) | Natural Products | Comment (Nat. Pro.) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.1.150 | ATP + 1-phosphatidyl-1D-myo-inositol 3-phosphate | Homo sapiens | - |
ADP + 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate | - |
? |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.7.1.150 | Homo sapiens | Q9Y2I7 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.7.1.150 | astroglial cell | astroglial SVG-A derived cells | Homo sapiens | - |
2.7.1.150 | SVG-A cell | astroglial-derived cells | Homo sapiens | - |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.7.1.150 | ATP + 1-phosphatidyl-1D-myo-inositol 3-phosphate | - |
Homo sapiens | ADP + 1-phosphatidyl-1D-myo-inositol 3,5-bisphosphate | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.7.1.150 | class III lipid kinase | - |
Homo sapiens |
2.7.1.150 | phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase | - |
Homo sapiens |
2.7.1.150 | PI-3P-5-kinase | - |
Homo sapiens |
2.7.1.150 | PIKfyve | - |
Homo sapiens |
EC Number | Cofactor | Comment | Organism | Structure |
---|---|---|---|---|
2.7.1.150 | ATP | - |
Homo sapiens |
EC Number | General Information | Comment | Organism |
---|---|---|---|
2.7.1.150 | malfunction | the intracellular trafficking of pathogens, Zaire EBOV GP (VSV-MeGFPZEBOV) and SARS-CoV-2 S Wuhan-Hu-1 strain (VSV-eGFP-SARS-CoV-2), is elicited by inhibition of PIKfyve kinase via apilimod and vacuolin-1, small-molecule inhibitors of the main endosomal phosphatidylinositol-3-phosphate/phosphatidylinositol 5-kinase, PIKfyve | Homo sapiens |
2.7.1.150 | physiological function | analysis of the intracellular trafficking of pathogens elicited by inhibition of PIKfyve kinase | Homo sapiens |